Allakos
AcquiredSan Francisco, United States · Founded 2012 · $10.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2012
- Business Model
- B2B
- Website
- allakos.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series ADec 2012
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds for this company. The full record is or through the API.
About
Biotechnology company developing antibodies targeting receptors that modulate the activity of immune effector cells involved in inflammation and tissue damage.
Summary
Allakos is a Biotech company based in San Francisco, United States, founded in 2012. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Dec 2012.
Funding & Exit History
Jul 2018
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/allakos"><img src="https://indexed.vc/api/badge/company/allakos" alt="Allakos on Indexed.vc" width="260" height="76" /></a>